Fierce Pharma

After a yearslong struggle, Jazz Pharmaceuticals has called time on [...]

Combining the two drugmakers would trigger severe regulatory concerns and [...]

Novartis’ blockbuster radioligand therapy Pluvicto has cleared a key milestone [...]

Amylyx’s patient education website aims to empower patients to navigate [...]

A notice from the Health Resources & Services Administration sidelines [...]

A Daiichi Sankyo quarterly report that should have celebrated strong [...]

Seven years after it was approved, AbbVie’s Skyrizi has proven [...]

Reporting a new miss in one indication, Karyopharm is plowing [...]

Shionogi’s “Got the Call, Make the Call” campaign for COVID [...]

Legend Biotech’s Ying Huang, Ph.D., resigned after a six-year stint [...]